8-K: Datavault AI Faces Nasdaq Delisting, Moves to OTC Markets

Sentiment:

Current Report (8-K)


Datavault AI Inc. announced it received a notice of delisting from Nasdaq due to non-compliance with the $1.00 bid price requirement, leading to a trading suspension and eligibility to trade on OTC Markets.

Worse than expectedThe company is facing delisting from Nasdaq due to non-compliance with the minimum bid price rule ($1.00) and a low stock price rule (closing bid price below $0.10 for ten consecutive business days).Trading will be suspended on Nasdaq, moving the stock to the OTC Markets, which is generally considered a less prestigious and less liquid trading venue.

Summary

  • Datavault AI Inc. received a notification from Nasdaq on November 10, 2026, indicating its common stock is subject to delisting.
  • The reason for delisting is non-compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00.
  • Trading in the company's securities will be suspended on Nasdaq effective November 17, 2026, due to a closing bid price below $0.10 for ten consecutive business days.
  • The company's common stock is expected to be eligible to trade on the OTC Markets under the symbol DVLT starting November 17, 2026.
  • Datavault AI intends to request a hearing before the Nasdaq Hearings Panel to present a plan for regaining compliance and maintaining its Nasdaq listing.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the impending delisting from Nasdaq and the move to OTC markets, indicating significant financial distress and listing rule non-compliance.

Positives

  • The company intends to request a hearing with the Nasdaq Hearings Panel to appeal the delisting decision.
  • The company's common stock is expected to remain tradable on the OTC Markets, providing some liquidity for shareholders.

Negatives

  • The company's common stock is subject to delisting from Nasdaq due to failure to meet the $1.00 minimum bid price requirement.
  • Trading on Nasdaq will be suspended effective November 17, 2026, due to a closing bid price below $0.10 for ten consecutive business days.
  • There is no assurance that the Nasdaq Hearings Panel will grant the company's request for continued listing or an extension to regain compliance.

Risks

  • The primary risk is the potential permanent delisting from Nasdaq, which could significantly reduce the stock's liquidity and investor base.
  • There is no guarantee that the company will be able to regain compliance with Nasdaq's bid price requirement within any granted extension period.
  • Trading on the OTC Markets may result in lower trading volumes and potentially higher volatility compared to Nasdaq.
  • There is no assurance that a broker will continue to make a market in the company's common stock on the OTC Markets.

Future Outlook

The company plans to request a hearing with the Nasdaq Hearings Panel to present a plan to regain compliance with the bid price requirement and seek an extension for continued listing. However, there is no assurance of a favorable outcome or the ability to regain compliance.

Management Comments

  • The Company intends to request a hearing before the Nasdaq Hearings Panel in an effort to maintain its Nasdaq listing and reinitiate trading of its Common Stock on Nasdaq.
  • At the hearing, the Company will present its plan to evidence compliance with the Bid Price Rule and request an extension of time to do so as well as the reinitiation of trading and continued listing of the Companys securities on Nasdaq as a result thereof.
  • There can be no assurances that the Panel will grant the Companys request for continued listing on Nasdaq or if it does so that the Company will be able to regain compliance with the extension period that may be granted by the Panel.

Industry Context

StockSavvy.ai notes that Nasdaq delisting due to low bid prices is a common challenge for smaller companies, often signaling financial distress or a lack of investor confidence. The move to OTC markets is a typical, albeit less desirable, alternative for continued trading.

Stakeholder Impact

  • Shareholders may experience reduced liquidity and potentially a decrease in stock value due to the move from Nasdaq to OTC Markets.
  • Investors may face increased difficulty in trading the stock and potentially wider bid-ask spreads on the OTC Markets.

Next Steps

  • Request a hearing before the Nasdaq Hearings Panel.
  • Present a plan to evidence compliance with the Bid Price Rule.
  • Seek an extension of time to regain compliance with Nasdaq listing rules.
  • Continue trading on OTC Markets under the symbol DVLT.

Key Dates

DateDescription
2026-11-10Date the company received the letter from Nasdaq regarding non-compliance with the Bid Price Rule.
2026-11-17Effective date for the suspension of trading on Nasdaq and eligibility to trade on OTC Markets.
2026-11-13Date the press release announcing the Nasdaq notice and trading suspension was issued.

Recommendation

sell

The impending delisting from Nasdaq and move to the OTC markets, driven by sustained non-compliance with listing requirements, indicates severe financial distress and a high risk of further value erosion. While a hearing is planned, the outcome is uncertain, and the transition to OTC markets typically leads to reduced liquidity and investor interest, making it a sell signal.

Keywords

Nasdaq delisting, OTC Markets, bid price requirement, trading suspension, listing compliance, Datavault AI

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.